why choose us

Course: Intranasal Naloxone for Opioid Overdose

CME Credits: 1.00

Released: 2023-12-21

In 2021, opioid overdose deaths exceeded 80,000 in the US.1 Naloxone, a competitive opioid receptor antagonist that reverses symptoms of opioid intoxication and overdose by displacing opioids from ?-opioid receptors, is a safe and effective medication for preventing opioid overdose death. Naloxone meets US Food and Drug Administration (FDA) criteria for approval without a prescription: its benefits outweigh risks, it treats a condition that can be identified by people in the community, it has a low potential for misuse, and it can be labeled to facilitate correct administration.


To identify the key insights or developments described in this article


View Full Course